Alnylam Pharmaceuticals (ALNY) Enterprise Value Growth (3y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.75% |
| Dec 31, 2025 | -48.03% |
| Sep 30, 2025 | -6.71% |
| Jun 30, 2025 | -11.17% |
| Mar 31, 2025 | 22.52% |
| Dec 31, 2024 | 25.59% |
| Sep 30, 2024 | 1.69% |
| Jun 30, 2024 | -48.51% |
| Mar 31, 2024 | -12.61% |
| Dec 31, 2023 | -9.84% |
| Sep 30, 2023 | -10.48% |
| Jun 30, 2023 | 28.05% |
| Mar 31, 2023 | -16.17% |
| Dec 31, 2022 | 16.22% |
| Sep 30, 2022 | -9.22% |
| Jun 30, 2022 | -2.58% |
| Mar 31, 2022 | -21.05% |
| Dec 31, 2021 | -29.75% |
| Sep 30, 2021 | -52.09% |
| Jun 30, 2021 | -28.81% |
| Mar 31, 2021 | -1.77% |
| Dec 31, 2020 | -2.69% |
| Sep 30, 2020 | -23.28% |
| Jun 30, 2020 | -25.83% |
| Mar 31, 2020 | -32.79% |
| Dec 31, 2019 | -35.03% |
| Sep 30, 2019 | -35.00% |
| Jun 30, 2019 | -31.72% |
| Mar 31, 2019 | -67.42% |
| Dec 31, 2018 | -67.18% |
| Sep 30, 2018 | -20.87% |
| Jun 30, 2018 | -20.05% |
| Mar 31, 2018 | -17.48% |
| Dec 31, 2017 | -41.12% |
| Sep 30, 2017 | -17.09% |
| Jun 30, 2017 | -15.11% |
| Mar 31, 2017 | 5.76% |
| Dec 31, 2016 | -36.06% |
| Sep 30, 2016 | -53.40% |
| Jun 30, 2016 | -59.01% |
| Mar 31, 2016 | -3.96% |
| Dec 31, 2015 | -23.67% |
| Sep 30, 2015 | 6.31% |
| Jun 30, 2015 | -64.76% |
| Mar 31, 2015 | -69.35% |
| Dec 31, 2014 | -60.22% |
| Sep 30, 2014 | -50.57% |
| Jun 30, 2014 | -40.56% |
| Mar 31, 2014 | -39.60% |
| Dec 31, 2013 | -1.79% |
| Sep 30, 2013 | 5.74% |
| Jun 30, 2013 | 6.82% |
| Mar 31, 2013 | -27.10% |
| Dec 31, 2012 | 24.15% |
| Sep 30, 2012 | -32.53% |
| Jun 30, 2012 | 31.14% |